News
PHR
20.46
-6.75%
-1.48
Weekly Report: what happened at PHR last week (0415-0419)?
Weekly Report · 3d ago
Phreesia (NYSE:PHR): A Value Play in Healthcare Tech
Phreesia (NYSE:PHR) is a technology provider that caters to the healthcare industry. The stock has shed a third of its value over the past year. Phreesia is well-positioned for tremendous growth. The company is projected to facilitate 150 million patient visits in fiscal year 2024.
TipRanks · 4d ago
Phreesia (PHR) Shares Cross Below 200 DMA
NASDAQ · 04/18 15:38
Weekly Report: what happened at PHR last week (0408-0412)?
Weekly Report · 04/15 09:29
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Phreesia, Inc. Is currently trading at a low price of US$23.80 on the NYSE. The small-cap company is expected to grow by 61% over the next few years. The company is currently undervalued, but its future growth isn't fully reflected in the share price. Phreesia's share price has been volatile in the last few months, but is still a good opportunity to buy the stock.
Simply Wall St · 04/12 10:09
Have Insiders Sold Phreesia Shares Recently?
Co-Founder of Phreesia, Inc. Recently divested US$272k worth of shares in the company. Chaim Indig sold shares at an average price of US$22.62 each. In the last year the company has seen no insider purchases of shares. Insiders own 5.2% of Phreeia, but the company didn't buy any shares over the last years. Phreesa is not a good stock to buy.
Simply Wall St · 04/12 10:04
Phreesia: Report of proposed sale of securities
Press release · 04/10 22:17
R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space
R1 RCM, Health Catalyst downgraded as KeyBanc Capital Markets downgrades the stocks ahead of Q1 earnings. The firm upgraded GoodRx Holdings and Certara ahead of the healthcare IT space. The analyst cited the recent cybersecurity incident at UnitedHealth's Change Healthcare unit.
Seeking Alpha · 04/10 16:56
Phreesia: Report of proposed sale of securities
Press release · 04/09 00:05
Weekly Report: what happened at PHR last week (0401-0405)?
Weekly Report · 04/08 09:30
Piper Sandler Sticks to Their Buy Rating for Phreesia (PHR)
TipRanks · 04/05 10:47
Phreesia Continues To Stay Positive On The Business Growth
Phreesia is expected to continue growing revenue at a rate of 20%+ and see an increase in adjusted EBITDA margin as the business scales. The company has added new products to contribute to revenue growth. Management has raised profitability guidance for FY25. Phreesia saw very strong revenue growth of 24.1% in the 4Q24 quarter.
Seeking Alpha · 04/03 04:18
Weekly Report: what happened at PHR last week (0325-0329)?
Weekly Report · 04/01 09:30
Analysts Offer Insights on Healthcare Companies: ProSomnus (OSA), Merck & Company (MRK) and Phreesia (PHR)
TipRanks · 03/27 12:30
Phreesia (PHR) Shares Cross Above 200 DMA
NASDAQ · 03/26 20:27
Weekly Report: what happened at PHR last week (0318-0322)?
Weekly Report · 03/25 09:31
Phreesia Price Target Maintained With a $23.00/Share by RBC Capital
Dow Jones · 03/21 15:24
RBC Capital Reiterates Sector Perform on Phreesia, Maintains $23 Price Target
Benzinga · 03/21 15:14
Phreesia Price Target Raised to $30.00/Share From $28.00 by JMP Securities
Dow Jones · 03/21 14:27
More
Webull provides a variety of real-time PHR stock news. You can receive the latest news about Phreesia through multiple platforms. This information may help you make smarter investment decisions.
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.